A
Achieve Life Sciences, Inc. (ACHV)
NCM – Real vaqt narxi. Valyuta: USD
6.69
-0.08 (-1.18%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
6.73
+0.04 (0.60%)
Bozordan keyin: Aug 12, 2026, 4:13 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
6.69
-0.08 (-1.18%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
6.73
+0.04 (0.60%)
Bozordan keyin: Aug 12, 2026, 4:13 PM EDT
Achieve Life Sciences, Inc., kechki bosqichdagi farmatsevtika kompaniyasi bo'lib, Kanadada, Qo'shma Shtatlarda va Buyuk Britaniyada nikotin mustaqilligi uchun sitiziniklinni ishlab chiqadi va tijoratlashtiradi. Kompaniya miyadagi nikotin retseptorlari bilan o'zaro ta'sir qiladigan va nikotinni to'xtatish alomatlarining og'irligini kamaytiradigan tabiiy alkaloid bo'lgan sitiziniklinni taklif etadi. U Sopharma AD va Bristol universiteti bilan litsenziya va ta'minot shartnomalariga ega. Achieve Life Sciences, Inc., Bothell, Vashingtonda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Andrew D. Goldberg M.D. | CEO, President & Director |
| Mr. Erik Atkisson | Chief Legal Officer |
| Mr. Mark K. Oki CPA | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-07-06 | 8-K | achv-20260702.htm |
| 2026-06-08 | DEF 14A | achv-20260604.htm |
| 2026-06-08 | ARS | proxy_2026_ars.pdf |
| 2026-06-02 | 8-K | achv-20260529.htm |
| 2026-05-29 | PRE 14A | achv-20260529.htm |
| 2026-05-19 | CORRESP | filename1.htm |
| 2026-05-12 | S-8 | achv-20260512.htm |
| 2026-05-12 | S-3 | achv-20260512.htm |
| 2026-05-12 | 8-K | d854692d8k.htm |
| 2026-04-30 | 10-K/A | achv-20251231.htm |